Pharmaceutical Group Says Viagra Bill Unfair to Poor Men

July 7, 2008 - 8:22 PM

(CNSNews.com) - A pharmaceutical group is warning Congress not to restrict funding of erectile dysfunction drugs, because it will unfairly affect disadvantaged, low-income elderly men who suffer from medical conditions that cause impotence.

The U.S. House Friday voted to ban Medicare or Medicaid payments for impotency drugs. The Pharmaceutical Research and Manufacturers of America (PhRMA) said erectile dysfunction is a consequence of disease and products like Viagra are part of the overall treatment of the condition.

"The real losers are the hundreds of thousands of disadvantaged, low-income and senior men in America who suffer from diabetes, prostate cancer, heart disease and depression. Erectile dysfunction is often a consequence of the se debilitating diseases, and products that address ED are part of their overall treatment," said PhRMA Senior Vice President Ken Johnson.

"Unfortunately, the House is telling these men: tough luck ... you're on your own. Hopefully, the Senate will view this important health issue with a little more compassion," said Johnson.

"Medicare and Medicaid patients should not be second class citizens when their diseases are treated. They, too, should have access to the most effective treatments in consultation with their physicians," he added.

See Also:
House Okays Bill Banning Government Funding of Viagra Use (June 24, 2005)


Send a Letter to the Editor about this article.